Cardiac Function Improvement and Bone Marrow Response Outcome Analysis of the Randomized Perfect Phase III Clinical Trial of Intramyocardial CD133+ Application After Myocardial Infarction Gustav Steinhoff, Julia Nesteruk, Markus Wolfien, Guenther Kundt, Jochen Boergermann, Robert David, Jens Garbade, Jana grosse, Axel Haverich, Holger Hennig, Alexander Kaminski, Joachim Lotz, Friedrich W Mohr, Paula Mueller, Robert...
The overall objective of the SysMedPD project is to further explore and identify novel drug candidates capable of slowing down the progression of neurodegeneration in the subset of Parkinson’s Disease (PD) patients with overt mitochondrial dysfunction.
The Coordinating Action Systems Medicine (CASyM) in collaboration with the Federation of European Biochemical Societies (FEBS) organized the first European Summer School in Systems Medicine: Implementation of Systems Medicine across Europe.
This book introduces the emerging field of systems medicine and describes a transition in modern biomedical research. It is the first book of its kind and it contains contributions from leading experts from across Europe.
“Avicenna – A Strategy for in silico Clinical Trials” was a Coordination and Support Action funded by the European Commission. Avicenna was tasked with writing a Roadmap to define the strategy for developing In Silico Clinical Trials.